Fountain, M.D.* ; Oleson, D.S.* ; Rech, M.E.* ; Segebrecht, L.* ; Hunter, J.V.* ; McCarthy, J.M.* ; Lupo, P.J.* ; Holtgrewe, M.* ; Moran, R.* ; Rosenfeld, J.A.* ; Isidor, B.* ; Le Caignec, C.* ; Saenz, M.S.* ; Pedersen, R.C.* ; Morgan, T.M.* ; Pfotenhauer, J.P.* ; Xia, F.* ; Bi, W.* ; Kang, S.H.L.* ; Patel, A.* ; Krantz, I.D.* ; Raible, S.E.* ; Smith, W.* ; Cristian, I.* ; Torti, E.* ; Juusola, J.* ; Millan, F.* ; Wentzensen, I.M.* ; Person, R.E.* ; Küry, S.* ; Bézieau, S.* ; Uguen, K.* ; Férec, C.* ; Munnich, A.* ; van Haelst, M.* ; Lichtenbelt, K.D.* ; van Gassen, K.* ; Hagelstrom, T.* ; Chawla, A.* ; Perry, D.L.* ; Taft, R.J.* ; Jones, M.* ; Masser-Frye, D.* ; Dyment, D.* ; Venkateswaran, S.* ; Li, C.* ; Escobar, L.F.* ; Horn, D.* ; Spillmann, R.C.* ; Peña, L.* ; Wierzba, J.* ; Strom, T.M. ; Parenti, I.* ; Kaiser, F.J.* ; Ehmke, N.* ; Schaaf, C.P.*
Pathogenic variants in USP7 cause a neurodevelopmental disorder with speech delays, altered behavior, and neurologic anomalies.
Genet. Med. 21, 1797-1807 (2019)
Purpose: Haploinsufficiency of USP7, located at chromosome 16p13.2, has recently been reported in seven individuals with neurodevelopmental phenotypes, including developmental delay/intellectual disability (DD/ID), autism spectrum disorder (ASD), seizures, and hypogonadism. Further, USP7 was identified to critically incorporate into the MAGEL2-USP7-TRIM27 (MUST), such that pathogenic variants in USP7 lead to altered endosomal Factin polymerization and dysregulated protein recycling.Methods: We report 16 newly identified individuals with heterozygous USP7 variants, identified by genome or exome sequencing or by chromosome microarray analysis. Clinical features were evaluated by review of medical records. Additional clinical information was obtained on the seven previously reported individuals to fully elucidate the phenotypic expression associated with USP7 haploinsufficiency.Results: The clinical manifestations of these 23 individuals suggest a syndrome characterized by DD/ID, hypotonia, eye anomalies, feeding difficulties, GERD, behavioral anomalies, and ASD, and more specific phenotypes of speech delays including a nonverbal phenotype and abnormal brain magnetic resonance image findings including white matter changes based on neuroradiologic examination.Conclusion: The consistency of clinical features among all individuals presented regardless of de novo USP7 variant type supports haploinsufficiency as a mechanism for pathogenesis and refines the clinical impact faced by affected individuals and caregivers.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Usp7 ; Neurodevelopment ; Speech Delay ; White Matter Paucity ; Corpus Callosum Thinning; Prader-willi-syndrome; Corpus-callosum; Children; Mutations; Abnormalities; Hausp; P53
Keywords plus
Language
Publication Year
2019
Prepublished in Year
HGF-reported in Year
2019
ISSN (print) / ISBN
1530-0366
e-ISSN
1098-3600
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 21,
Issue: 8,
Pages: 1797-1807
Article Number: ,
Supplement: ,
Series
Publisher
Lippincott Williams & Wilkins
Publishing Place
Baltimore, Md.
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30501 - Systemic Analysis of Genetic and Environmental Factors that Impact Health
Research field(s)
Genetics and Epidemiology
PSP Element(s)
G-500700-001
Grants
Copyright
Erfassungsdatum
2019-03-12